Belmont Cancer Survivor Pamela Bou Sejean Launches Plan to Help Others

When Belmont’s Pamela Bou Sejean was looking for a lifesaving stem cell match she knew it would be like finding a needle in a haystack.

A match is more likely in someone who shares the same ethnic background — but only 0.6 per cent of all the donors on Australian Bone Marrow Donor Register have a Middle Eastern background like Ms Bou Sejean.

While her remission from Hodgkin Lymphoma came from a cord blood match, Ms Bou Sejean had seen the void and knew it had to be filled.

The Facebook page which took her plea for life around the world in 2012 has been turned into Ur the Cure, an organisation raising awareness of the need for those from ethnic backgrounds to join the registry.

She’s run blood drives at church and community groups, spoke at last month’s Survivorship Conference in Adelaide and will present at Saturday’s Scott No Cancer fundraiser for Geelong West’s Scott Beyer who has a rare Non-Hodgkin Lymphoma.

“The reaction I get from most people, is why hasn’t this been done already,” Ms Bou Sejean said. “But I’m doing it now.”

Ur the Cure will publicise those seeking a match, lobby government and health organisations to make the register more prominent and dispel myths associated with donating bone marrow — now a near-painless procedure.

“Cancer doesn’t discriminate, children, adults, whatever religion or background it can get anyone,” Ms Bou Sejean said.

“One woman who contacted me through the page needed a match 15 years ago from an Asian background and she couldn’t believe nothing had changed.”

The organisation’s website shows how other countries promote their Bone Marrow Registries through emotional footage of people meeting the donors who saved their lives — something Ms Bou Sejean hopes to one day do too.

“It could be as simple as a tick box to join when you give blood or a broad campaign like organ donation or combining with programs that already exist like the Red Cross youth ambassador programs or school education talks,” she said.

“There’s massive room for improvement. It’s curing and saving people’s lives.”

Ms Bou Sejean will also travel to Lebanon later this year to reignite plans for the country’s first Bone Marrow Register, which will link in with the worldwide register.

Those aged 18-45 can join the Australian Bone Marrow Donor Registry by phoning the Red Cross Blood Service on 13 14 95 and making an appointment to donate blood and join the registry.

Republished with permission Gelong Advertiser, March 27 2015

Share This

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.